BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van der Put RMF, Smitsman C, de Haan A, Hamzink M, Timmermans H, Uittenbogaard J, Westdijk J, Stork M, Ophorst O, Thouron F, Guerreiro C, Sansonetti PJ, Phalipon A, Mulard LA. The First-in-Human Synthetic Glycan-Based Conjugate Vaccine Candidate against Shigella. ACS Cent Sci 2022;8:449-60. [PMID: 35559427 DOI: 10.1021/acscentsci.1c01479] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Del Bino L, Østerlid KE, Wu DY, Nonne F, Romano MR, Codée J, Adamo R. Synthetic Glycans to Improve Current Glycoconjugate Vaccines and Fight Antimicrobial Resistance. Chem Rev 2022. [PMID: 35608633 DOI: 10.1021/acs.chemrev.2c00021] [Reference Citation Analysis]
2 Phalipon A, Mulard LA. Toward a Multivalent Synthetic Oligosaccharide-Based Conjugate Vaccine against Shigella: State-of-the-Art for a Monovalent Prototype and Challenges. Vaccines 2022;10:403. [DOI: 10.3390/vaccines10030403] [Reference Citation Analysis]